Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New findings on the role of IFN-alpha in diabetes reported

Jan. 26, 1999

WHO maintains importance of male contraceptive research

Jan. 26, 1999

Hypoglycemic/hypoinsulinemic chromium complexes designed at Otsuka

Jan. 26, 1999

New insulin sensitizer is a coligand for PPARalpha and PPARgamma receptors

Jan. 25, 1999

FDA grants priority review to SB's Avandia

Jan. 22, 1999

Unigene obtains E.U. approval for injectable calcitonin product

Jan. 22, 1999

Novel squalene synthase inhibitors claimed by Nippon Kayaku

Jan. 22, 1999

JT reports novel antidiabetic agent that has advanced to clinical trials

Jan. 21, 1999

Nippon Kayaku patents novel squalene synthase inhibitors

Jan. 21, 1999

Tyrosine kinase and bone resorption inhibitor isolated from fungus by Takeda

Jan. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...